Lymphoid cells that express the nuclear hormone receptor RORgt are involved in containment of the large intestinal microbiota and defense against pathogens through the production of interleukin 17 (IL-17) and IL-22. They include adaptive IL-17-producing helper T cells (T H 17 cells), as well as innate lymphoid cells (ILCs) such as lymphoid tissue-inducer (LTi) cells and IL-22-producing NKp46 + cells. Here we show that in contrast to T H 17 cells, both types of RORgt + ILCs constitutively produced most of the intestinal IL-22 and that the symbiotic microbiota repressed this function through epithelial expression of IL-25. This function was greater in the absence of adaptive immunity and was fully restored and required after epithelial damage, which demonstrates a central role for RORgt + ILCs in intestinal homeostasis. Our data identify a finely tuned equilibrium among intestinal symbionts, adaptive immunity and RORgt + ILCs.
A r t i c l e s
The mammalian intestine hosts a large microbiota that includes an estimated 1 × 10 14 bacteria and 1 × 10 2 to 1 × 10 3 individual species 1 . To contain this microbiota and fight breaches by invading microbes, the intestinal immune system deploys a complex network of lymphoid tissues and cells 2, 3 . Part of this system, such as mesenteric lymph nodes and Peyer's patches, is programmed to develop during ontogeny, and part of it, such as the formation of numerous isolated lymphoid follicles from preformed cryptopatches and the recruitment of various subsets of intestinal lymphocytes, is induced by the microbiota 4 . An equilibrium is established between the microbiota and the immune system that is fundamental to intestinal homeostasis 5, 6 . Perturbation of homeostasis leads either to inflammatory disease characterized by immune attack on microbial symbionts and tissue destruction, the scenario that unfolds during inflammatory bowel disease, or (in contrast) to low reactivity of the intestinal immune system and greater susceptibility to pathogens 7 .
Many cytokines have a key role in intestinal homeostasis. Whereas proinflammatory cytokines such as interferon-γ (IFN-γ), interleukin 17 (IL-17) and tumor necrosis factor promote the elimination of intruding microbes, the anti-inflammatory cytokines IL-10 and transforming growth factor-β limit the amplitude of inflammation and favor the production and secretion of immunoglobulin A, which is essential to mucosal immunity 2, 3 . Another member of the IL-10 cytokine family, IL-22, has been shown to directly induce epithelial defense through the expression of antimicrobial peptides such as β-defensins 8 , S100A7 (psoriasin), S100A8 (calgranulin A), S100A9
(calgranulin B) 9 , RegIIIβ and RegIIIγ 10 . IL-22 has a critical role in defense against attaching and effacing bacterial pathogens in the intestine, such as Citrobacter rodentium 10, 11 , against Gram-negative bacteria in the lung, such as Klebsiella pneumoniae 12 , and against the fungus Candida albicans 13 . IL-22 also induces antiapoptotic molecules, such as members of the Bcl-2 family, through activation of the transcription factor STAT3 (ref. 14) and, as a possible consequence, protects colon and hepatocytes from acute inflammation 15, 16 .
IL-22 is efficiently induced by and is produced in large amounts not only by CD4 + IL-17-producing helper T cells (T H 17 cells) 18, 19 but also by other subsets of helper T cells 20 , CD8 + T cells, γδ T cells 18 and natural killer (NK) cells 16, 21 . It has been shown that a subset of mucosal innate lymphoid cells (ILCs) that express the pan-NK cell markers NKp46 in the mouse and NKp44 in humans also express IL-22 (refs. 22-27) and that mice lacking these IL-22 + NKp46 + cells are more susceptible to infection with C. rodentium 23 . It has also been shown that CD4 + lineage-negative cells in the spleen, a phenotype reminiscent of that of the lymphoid tissue-inducer (LTi) cells required for the development of secondary lymphoid tissues 28 and isolated lymphoid follicles in the intestine 29 , express IL-22 (refs. 11,30,31) . 25, 35 , is development induced by the intestinal symbiotic microbiota.
Using transgenic reporter mice expressing enhanced green fluorescent protein under control of the locus encoding RORγt on a bacterial artificial chromosome (Rorc-GFP mice) 36 , we now show that RORγt + ILCs, including IL-22 + NKp46 + cells and LTi cells, produced most of the intestinal IL-22. In contrast to its expression in T cells, this expression of IL-22 was constitutive, highest before weaning and independent of microbial colonization. However, the microbiota repressed the production of IL-22 by RORγt + ILCs through the expression of IL-25 in epithelial cells, whereas the role of IL-23 was minimal. The IL-22-producing activity and number of RORγt + ILCs were greater in the absence of adaptive immunity and RORγt + T cells, presumably as a consequence of larger niche availability. Furthermore, after epithelial damage and consequent intestinal inflammation, RORγt + ILCs regained full activity and were required for survival and recovery.
Collectively, our data demonstrate that IL-22 production by RORγt + ILCs is programmed and regulated by the microbiota and adaptive immunity, presumably to maintain a necessary equilibrium between the microbiota and the various forces of immunity.
RESULTS

RORgt + ILCs are the main source of intestinal IL-22
RORγt is expressed by T cells 32, 36 and NKp46 + or NKp44 + cells that produce . To determine the proportion of intestinal IL-22 + cells among RORγt + cells, we examined Rorc-GFP mice 36 . We found that in mouse fetuses at embryonic day 15 (E15), mice not yet weaned (2 weeks of age) and adult mice (8 weeks of age), most IL-22 + cells expressed RORγt (Fig. 1a) . The vast majority of IL-22 + cells (99%, 80% and 83%, at E15, 2 weeks and 8 weeks, respectively) did not express CD3ε, and IL-22 + CD4 + T cells (which include T H 17 cells) represented only 11% of the total IL-22 + cells in the adult. Mice deficient in the RAG-2 recombinase component, which lack T cells, did not have significantly lower Il22 expression in the small intestine, whereas mice deficient in RORγt alone or mice deficient in both RAG-2 and RORγt, which lack RORγt + cells, had no detectable expression of Il22 (Fig. 1b) and consequently lower expression of the genes encoding the antimicrobial peptides RegIIIβ (Reg3b) and RegIIIγ (Reg3g; Fig. 1c ). These results demonstrate that most intestinal IL-22 is produced by RORγt + ILCs.
In the fetus, RORγt + ILCs consist mainly of CD4 + LTi cells 33 , whereas after birth, the pool of CD4 − RORγt + ILCs, including CD4 − LTi cells 37 , expanded, and NKp46 + RORγt + ILCs were generated (Fig. 1d) . RORγt + ILCs were present mostly in the intestinal lamina propria (Supplementary Fig. 1a ) and did not include B cells, dendritic cells (DCs) or cells of the monocyte-macrophage lineage ( Supplementary  Fig. 1b) . The expression of IL-22 by RORγt + ILCs was highest in fetal mice and mice not yet weaned and decreased considerably thereafter (Fig. 2a) . We noted a similar expression profile for IL-17 in CD4 + LTi cells (Fig. 2b) ; a sizeable fraction of IL-22 + cells expressed IL-17 as well as IL-22 ( Supplementary Fig. 2a,b) . After birth, RORγt + ILCs also had lower expression of genes involved in lymphoid tissue development, such as Lta (which encodes lymphotoxin α; Fig. 2c ) and Tnfsf11 (which encodes Trance 38 ; Supplementary Fig. 2c ). The expression of Ifng transcripts, produced by the NK1.1 + subset of RORγt + NKp46 + cells 23 , was also lower after weaning (Fig. 2c) . Finally, the remaining CD4 − NKp46 − RORγt + ILCs (Fig. 1d) , which included c-Kit hi CD4 − LTi cells and poorly characterized c-Kit lo RORγt + ILCs expressing IFN-γ, also had lower expression of Il22, Il17, Lta and Ifng after weaning (Supplementary Fig. 3 ).
The microbiota represses IL-22 production by RORgt + ILCs The microbiota induces the generation of RORγt + T H 17 cells 34 and of the NK1.1 lo-neg subset of intestinal NKp46 + RORγt + ILCs 23, 25 . However, our data showed that LTi cells constitutively expressed 
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A r t i c l e s IL-22 in the sterile environment of the fetus and that expression of IL-22 by RORγt + ILCs was lower after weaning. As microbial colonization of the intestine increases considerably after weaning, we hypothesized that the symbiotic microbiota represses the activity of RORγt + ILCs. First, and in contrast to RORγt + T cells, the number of RORγt + ILCs remained unchanged in germ-free or antibiotic-treated Rorc-GFP mice ( Fig. 3a) , in accordance with data obtained for LTi cells 35 . These observations were valid for both LTi cells and NKp46 + RORγt + ILCs; the latter included varying proportions of NK1.1 hi cells reported to not be affected by the microbiota 23 .
Furthermore, the production of IL-22 by RORγt + ILCs was derepressed in adult germ-free and antibiotic-treated mice ( Fig. 3b) to concentrations reached in fetal mice and mice not yet weaned (Fig. 2a) . This microbiota-induced repression seemed specific for IL-22 production and not effective on IL-17 production (Fig. 3c) .
The microbiota represses RORγt + ILCs through IL-25
It has been reported that the differentiation of T H 17 cells in the colon of BALB/c mice is inhibited by IL-25 induced by the microbiota 39 . In accordance with those data, we found that Il25 expression was much lower in the ileal epithelium of germ-free mice than in that of specific pathogen-free (SPF) mice (Fig. 4a) . In addition, in SPF mice, Il25 expression by epithelial cells increased with age, presumably as a result of microbial colonization of the intestine. As this Il25 expression pattern was inversely correlated with the production of IL-22 by RORγt + ILCs, we assessed the activity of RORγt + ILCs in IL-25-deficient mice. Whereas the number of RORγt + ILCs was marginally greater in the absence of IL-25 ( Fig. 4b) , the production of IL-22 was significantly higher ( 24 ± 2.8 24 ± 3.8 ILCs ( Fig. 4d) and, as a probable consequence, inhibited the expression of Reg3b and Reg3g by epithelial cells (Fig. 4e) .
The inhibitory effect of IL-25 on RORγt + ILCs was indirect, as RORγt + ILCs did not express the IL-25 receptor (IL-25R (also called IL-17BR); Fig. 4f) . In contrast, IL-17BR was expressed by RORγt − ILCs, which are reported to expand their populations and produce IL-13 after the administration of IL-25 to mice and to be involved in early immunity to intestinal helminthes 40, 41 . IL-17RB was also expressed by CD11c + DCs in cryptopatches, which are clusters of LTi cells 29 . When we added IL-17BR + DCs to cultures of RORγt + ILCs, IL-25 efficiently repressed the production of IL-22 by RORγt + ILCs (Fig. 4g) , which demonstrated that IL-17RB + ILCs or DCs were able to mediate the inhibitory effect of IL-25 on the activity of RORγt + ILC. Transwell analysis showed that this inhibitory effect required contact between IL-17BR + DCs and RORγt + ILCs (Fig. 4h) , in accordance with published data showing that in mice deficient in the chemokine receptor CCR6 that develop abnormal cryptopatches, RORγt + ILCs have higher IL-22 expression than do those in wild-type mice 11, 30, 31 .
IL-23 is a potent inducer of and may be modulated by the microbiota and IL-25. We therefore assessed whether the enhanced IL-22 production by RORγt + ILCs in germ-free mice was a consequence of more IL-23 in intestinal tissues. However, as might be expected, Il23 expression was lower in germ-free mice (Supplementary Fig. 4a) . Furthermore, the absence of IL-25 or administration of IL-25 had no effect on the expression of Il23 or IL-23 protein (Supplementary Fig. 4b) , which excluded the possibility that IL-25 regulates the activity of RORγt + ILCs through IL-23, and Il23r expression by RORγt + ILCs was not modulated by IL-25 ( Supplementary Fig. 4c) . Finally, in IL-23p19-deficient mice that lack IL-23 ( Supplementary Fig. 4d ) and in wild-type mice treated with neutralizing antibody specific for the IL-23 receptor (IL-23R; Supplementary Fig. 4e ), the production of IL-22 by RORγt + ILCs and its repression by IL-25 were unaffected. Together these data show that IL-23 is not necessary for or involved in the regulation of IL-22 production by RORγt + ILCs.
Adaptive immunity represses the activity of RORγt + ILCs Both RORγt + T cells 18, 19 and RORγt + ILCs produce IL-22. These two cell types might therefore compete for regulating factors and thereby mutually regulate their activity. In accordance with this A r t i c l e s view, the production of IL-22 by RORγt + ILCs was much greater in mice deficient in RAG-2 (Fig. 5a) , and the absolute number of RORγt + ILCs was fourfold higher (Fig. 5b) . As noted earlier, the derepression of IL-22 production by RORγt + ILCs was only partial in IL-25-deficient mice, in contrast to that in germ-free mice (Figs. 3b  and 4c ). An additional level of repression is thus provided by adaptive immunity, possibly through RORγt + T cells that compete for a cytokine niche also occupied by RORγt + ILCs. As the microbiota induces the generation of RORγt + T H 17 cells 34 , our data indicate that the microbiota represses IL-22 production by RORγt + ILCs through both IL-25 and adaptive immunity. Of note, adaptive immunity was not required for the IL-25-mediated repression of IL-22 production by RORγt + ILCs, as the administration of IL-25 efficiently repressed this activity in RAG-2-deficient mice (Fig. 5c) .
Epithelial damage de-represses the activity of RORgt + ILCs
We next assessed the activity of RORγt + ILCs during intestinal inflammation. We induced epithelial damage by exposing Rorc-GFP mice orally to dextran sodium sulfate (DSS), which affects the colon and, to a lesser extent, the small intestine 42 . After two cycles of DSS administration followed by water, Il22 expression was much higher in the intestine (Fig. 6a) , as shown before 16 , concomitant with higher Il23 expression and much lower Il25 expression by epithelial cells. The IL-22 production by RORγt + ILCs was increased to concentrations found in germ-free mice (Figs. 6b and 3b) , and RORγt + ILC populations expanded three-to fourfold (Fig. 6c) . Thus, whereas the microbiota and adaptive immunity repress the activity of RORγt + ILCs in the steady state, epithelial damage that induces intestinal inflammation fully de-represses this activity and leads to the population expansion of RORγt + ILCs. Notably, even in the context of intestinal inflammation, IL-25 repressed IL-22 production by RORγt + ILCs (Fig. 6d) , which demonstrates its dominant role in the regulation of RORγt + ILCs.
Finally, we found that RORγt + ILCs were required for resistance to DSS-mediated colitis. Wild-type or RAG-2-deficient mice treated with IL-25 showed significantly more weight loss in response to DSS treatment, as well as delayed recovery (Fig. 7a,b) . In that context, IL-25 also resulted in fewer RORγt + T cells and repressed their production of IL-22 (Supplementary Fig. 5 ). However, mice that lack RORγt + ILCs rapidly succumbed to DSS-mediated colitis 43 , whereas RAG-2-deficient mice did not (Fig. 7b) . Of note, IL-25 efficiently repressed the expression of Reg3b and Reg3g (Fig. 4e) but only partially repressed A r t i c l e s IL-22 production by RORγt + ILCs (Figs. 4d, 6d and 7c,d) . In contrast, the absence of RORγt abolished the expression of Il22 (Fig. 1b) but not of Reg3b or Reg3g (Fig. 1c) , which indicated that the IL-22-producing activity of RORγt + ILCs was involved in the protection and recovery from DSS-mediated epithelial damage and colitis.
DISCUSSION
Lymphoid cells derived from common lymphoid progenitors 44 include B cells and T cells, the hallmarks of adaptive immunity, and ILCs, including NK cells and LTi cells 45 , which lack antigen receptors generated by somatic recombination. LTi cells, which express RORγt 33 , generate microinflammation at programmed sites in the fetus and in adult intestine to induce the development of lymphoid tissues 33, 35 . An additional subset of RORγt + ILCs has been described that resides mostly in the intestine. These cells express the pan-NK cell marker NKp46 but lack most other NK cell markers and are not cytotoxic [23] [24] [25] [26] [27] . We have now shown that RORγt + ILCs produced most of the intestinal IL-22 at steady state and markedly increased this activity during inflammation. RORγt + ILCs therefore have a critical role in intestinal homeostasis and defense, as IL-22 induces the production of antibacterial peptides by epithelial cells, is required for intestinal defense against bacterial and fungal pathogens [8] [9] [10] 12, 13 and is involved in the protection of intestinal tissues from the effects of pathological inflammation, presumably through the induction of antiapoptotic factors 15, 16 . In contrast to the number of RORγt + T cells 34 , the absolute number of RORγt + ILCs was unaffected in germ-free mice, which shows that the development of RORγt + ILCs is programmed 31 . This result may seem counterintuitive, as RORγt is induced in developing T H 17 cells through STAT3 activation 46, 47 . There is enrichment for T H 17 cells in the intestine 36 , where activators of STAT3 such as IL-6, IL-21 and IL-23 (ref. 48 ) abound, presumably in response to the large microbial community residing in the intestinal lumen. The microbiota also induces the generation of the NK1.1 lo-neg subset of RORγt + NKp46 + cells 23, 25, 26 . Nevertheless, RORγt seems to be programmed in thymic subsets of γδ T cells 49 and invariant NK T cells 50 , thus presumably in the absence of germs, and in LTi cells generated in the sterile environment of the fetus 28 .
In addition to demonstrating programmed development, RORγt + ILCs have constitutive expression of IL-22, as well as of IL-17 by LTi cells. The role of IL-22 and IL-17 produced by LTi cells in the fetus remains to be elucidated but seems to be evolutionary conserved in humans 27 . After birth, the key role of IL-22 in intestinal homeostasis and defense and more generally in mucosal immunity is well documented 10, 12, 13 . It may therefore be not unexpected that the immune system has evolved a constitutive pathway for IL-22 production.
However, as the size and structure of the intestinal symbiotic microbiota evolves with time, the amount of IL-22 produced might need constant readjustment. In accordance with that view, we have shown that the microbiota regulates IL-22-production by RORγt + ILCs. As components of the symbiotic microbiota, such as Candidatus arthromitus (also called segmented filamentous bacteria), have been shown to induce T H 17 cells 51, 52 , it will be important to assess whether segmented filamentous bacteria and other species or phyla of symbiotic bacteria regulate the activity of RORγt + ILCs.
We have shown that both the microbiota and adaptive immunity repressed the activity of RORγt + ILCs. It is possible that RORγt + T cells, including T H 17 cells 36 The microbiota seems to be a positive regulator of IL-22 produced by T H 17 cells but a negative regulator of IL-22 produced by innate RORγt + cells. In addition, adaptive immunity represses both the number of and IL-22-production by RORγt + ILCs. The microbiota might therefore repress the activity of RORγt + ILCs through both IL-25 and adaptive immunity. From the point of view of the host, RORγt + ILCs preempt colonization of the intestine by symbiotic microbiota, whereas adaptive immunity reacts to this colonization and regulates the preemptive innate immunity. This complex regulatory network probably reflects the superposition of adaptive immunity over the more ancient innate preemptive system and demonstrates the subtle interaction between the microbiota and the various forces of the vertebrate immune system in maintaining intestinal homeostasis.
Finally, the rupture in intestinal homeostasis induced by epithelial damage (achieved here by the administration of DSS) elicits a strong inflammatory reaction to contain the breaching symbiotic microbiota 53 . In that highly challenging context, populations of both T H 17 cells 36 and RORγt + ILCs expand and IL-22 production is highest. Thus, whereas in the steady state the microbiota, T H 17 cells and RORγt + ILCs are controlled by a complex regulatory network, during tissue damage and consequent inflammation, both adaptive and innate RORγt + cells 'sum up' their production of IL-22 to force a return to homeostasis. However, such situations are potentially dangerous to the host, as the proinflammatory activity of T H 17 cells and RORγt + ILCs may expand beyond control and induce inflammatory pathology [54] [55] [56] .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
